Solutions

The development of disease is a complex biochemical process. Treating a disease with a drug adds even more complexity to the biochemical and metabolic profile. Unraveling these complex interactions requires powerful tools.

Metabolon's biochemical profiling platform analyzes and identifies biochemicals on a global scale. The result is a complete picture of the biochemical landscape, showing the changes in ALL BIOCHEMICAL PATHWAYS. Analyzing the ways a disease or drug affects biochemical pathways provides insight into a variety of complex problems:

What markers define patients with the disease?
What disease target is the drug affecting?
What non-disease targets are being affected by the drug?
What global biochemical differences are seen with a series of drugs?

One Service, Many Solutions

Metabolon's global biochemical profiling service provides an unparalleled glimpse into complex biological systems. Solutions have been provided in a wide variety of areas, from drug development to biopharmaceutical manufacturing, from toothpaste to pet food, from seeds to cosmetics.

The broad utility of the platform arises from several factors:

Wide range of samples analyzed. Biochemicals have been analyzed from standard samples such as plasma, urine, cerebrospinal fluid, and cell culture media. Analysis has even been done on skin and crevicular fluid, the fluid between teeth and gum.

Diverse biochemicals identified. Metabolon's dual-mode LC-MS and GC-MS platform can detect a diverse set of biochemicals, polar, non-polar, and charged. All detected biochemicals are matched to our proprietary database, built on pure standards run over the last four years.

The result is the application of the technology to a wide range of areas: